#United States #Pleasanton #Healthcare Triangle #Kanzun #ARCB

Healthcare Triangle Partners with Kanzun-ARCB to Build US Corridor for AI and Healthcare

Healthcare Triangle, Inc. (Nasdaq: HCTI), a healthcare technology leader from the U.S., has officially joined forces with Kanzun Ventures Management Sdn. Bhd. and ARCB Investment LLC to establish a corridor facilitating the transition of Malaysian healthcare companies to the U.S. market. This strategic partnership was announced on September 17, 2026, following a memorandum of understanding signed in Kuala Lumpur, Malaysia. The initiative aims to connect promising Malaysian healthcare businesses with capital and expertise necessary to thrive on a global scale.

The arrangement details Healthcare Triangle's role as the technology and capital-markets partner, providing crucial AI, cloud, and data expertise that will help local companies prepare for their entrée into U.S. capital markets. The Kanzun-ARCB Growth Fund, which leverages ARCB's considerable financial resources and Kanzun's local industry insights, seeks to boost Malaysian healthcare businesses' innovative potential.

The Role of Each Partner

Kanzun Ventures will take the lead in identifying and evaluating Malaysian healthcare companies with strong growth prospects. Their responsibilities include deal sourcing, conducting due diligence, and portfolio development. ARCB, on the other hand, anchors the fund’s capital formation and leverages a robust investor network spanning the Middle East and Asia. Once Kanzun identifies viable target companies, Healthcare Triangle steps in, applying its wealth of experience in operating within Nasdaq-listed frameworks to enhance the market readiness of these firms.

Dr. Suresh Venkatachari, Healthcare Triangle's Founder and Head of M&A, expressed excitement about the collaboration. He emphasized the significance of supporting qualified Malaysian firms in their transition towards adopting AI technologies and evaluating pathways for expansion into the U.S. market.

Echoing this sentiment, Dr. Chaskar U., CEO of ARCB Group, noted that many healthcare entrepreneurs in Malaysia have established robust local businesses but often lack access to the necessary capital and governance structures to compete on an international scale. The partnership is designed to fill this critical gap by fostering a corridor that links Malaysian healthcare innovators with Middle Eastern capital and ultimately, U.S. markets.

A Vision for Future Growth

The partnership signifies a significant step towards creating an integrative ecosystem for Malaysian healthcare companies. By channeling investments and expertise from the U.S. into Malaysia, the initiative not only enhances the potential of local businesses but also elevates the healthcare standard within the region.

For Healthcare Triangle, the venture aligns perfectly with its ongoing commitment to advancing healthcare through technology. With solutions like CloudEz™ and DataEz™, Healthcare Triangle aims to assist these companies in navigating digital transformations while ensuring secure data practices, a crucial aspect of the highly regulated healthcare industry.

ARCB Investment, launched in 2022 and headquartered in the UAE, is focused on multiple sectors, including healthcare. It aims to promote sustainable growth through international partnerships, while Kanzun Ventures, a prominent name in venture capital, is committed to nurturing high-potential startups in the region.

Conclusion

The collaboration between Healthcare Triangle, Kanzun, and ARCB Investment marks a pioneering moment for Malaysian healthcare. By linking local companies to global markets and investment networks, this initiative opens up opportunities for growth and innovation. As this corridor develops, it promises to transform the healthcare landscape in Malaysia, paving the way for future advancements in both technology and patient care. This cooperation stands as a testament to the potential of cross-border partnerships in creating vibrant industry ecosystems.